Inhibitor Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inhibitor Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2016-12-31 was $0.00.
- Inhibitor Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2016-09-30 was $0.00.
- Inhibitor Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2015-12-31 was $0.00.
- Inhibitor Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2015-09-30 was $0.00.
- Inhibitor Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2016 was $2.66M, a 6.60% increase from fiscal 2015.
- Inhibitor Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2015 was $2.50M, a 900.00% increase from fiscal 2014.
- Inhibitor Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2014 was $250.00K, a 76.19% decline from fiscal 2013.
- Inhibitor Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2013 was $1.05M, a 2000.01% increase from fiscal 2012.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $2.66M 10-K · filed 2018-02-16 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-01 | $2.50M 10-K · filed 2016-02-01 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-01 | $250.00K 10-K · filed 2016-02-01 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $1.05M 10-K · filed 2015-02-13 |
| 2012-12-31 | $50.00K 10-K · filed 2014-04-15 |